Google Alert - lose weight

	lose weight As-it-happens update ⋅ March 19, 2026
	NEWS
	Weight-loss drugs may lower the risk of depression, anxiety, and self-harm, study finds Euronews.com GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, ... Flag as irrelevant
	Pythons' feast-and-famine life hints at new weight-loss pathway - Stanford Medicine Stanford Medicine - Stanford University ... identified molecules that skyrocket in their blood after a meal. One caused obese mice to eat less and lose weight, similar to semaglutide. Flag as irrelevant
	Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial Scientific American Retatrutide is among a new class of weight loss drugs being tested for their effectiveness. Flag as irrelevant
	FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight ... PR Newswire Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment* with Wegovy® HD (~19% regardless of whether ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback